Domnarvsgatan 4
Spånga 163 53
Sweden
46 87 44 77 00
https://www.boule.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 228
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Torben Nielsen | CEO & Group President | N/A | N/A | N/A |
Mr. Holger Lembrer M.Sc. | Chief Financial Officer | N/A | N/A | 1984 |
Mr. Eduardo Pagani | Chief Operating Officer | N/A | N/A | N/A |
Jorgen Jehander | Head of Development Department & Interim CTO | N/A | N/A | N/A |
Ms. Simonetta Tumbiolo | Senior Vice President of Marketing | N/A | N/A | N/A |
Ms. Aishat Bislieva | Senior Vice President of People & Culture | N/A | N/A | N/A |
Mr. Kiarash Farr | Senior Vice President of Commercial Operations | N/A | N/A | N/A |
David Metrena | Senior Vice President of Commercial Operations of US | N/A | N/A | N/A |
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Boule Diagnostics AB (publ)’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 8; Board: 7; Shareholder rights: 1; Compensation: 6.